当前位置: X-MOL 学术Lancet Global Health › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Dialysis in Africa: the need for evidence-informed decision making.
The Lancet Global Health ( IF 19.9 ) Pub Date : 2020-04-01 , DOI: 10.1016/s2214-109x(20)30058-9
Liam Crosby 1 , Peter Baker 2 , Peter Hangoma 3 , Edwine Barasa 4 , Vida Hamidi 5 , Kalipso Chalkidou 2
Affiliation  

Chronic kidney disease and acute kidney injury are leading causes of mortality and morbidity in sub-Saharan Africa. Chronic kidney disease accounts for 4 million disability-adjusted life-years (DALYs) lost across the continent annually, just behind diabetes (6·4 million DALYs). Increases in the prevalence of hypertension and type 2 diabetes are likely to increase the prevalence of chronic kidney disease in Africa, while high rates of intoxication and infections (such as malaria and HIV) drive acute kidney injury. Many people with acute kidney injury or advanced chronic kidney disease (ie, end-stage renal disease) require renal replacement therapy to remain alive.

中文翻译:

非洲透析:需要循证决策。

慢性肾病和急性肾损伤是撒哈拉以南非洲地区死亡和发病的主要原因。慢性肾病每年在整个非洲大陆造成 400 万残疾调整生命年 (DALYs),仅次于糖尿病(6·400 万 DALYs)。高血压和 2 型糖尿病患病率的增加可能会增加非洲慢性肾病的患病率,而高中毒率和感染率(如疟疾和艾滋病毒)会导致急性肾损伤。许多患有急性肾损伤或晚期慢性肾病(即终末期肾病)的人需要肾脏替代疗法才能维持生命。
更新日期:2020-03-19
down
wechat
bug